This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| bigram | frequency |
|---|---|
| dairy calves | 372 |
| cryptosporidium parvum | 229 |
| milk replacer | 223 |
| respiratory disease | 211 |
| escherichia coli | 194 |
| risk factors | 185 |
| calves fed | 169 |
| veal calves | 168 |
| neonatal calves | 141 |
| passive transfer | 139 |
| calf diarrhea | 134 |
| diarrheic calves | 129 |
| clinical signs | 129 |
| passive immunity | 112 |
| newborn calves | 107 |
| young calves | 106 |
| bovine respiratory | 96 |
| calf mortality | 95 |
| present study | 94 |
| halofuginone lactate | 93 |
| cryptosporidium spp | 93 |
| cryptosporidium infection | 92 |
| small intestine | 89 |
| management practices | 87 |
| dairy herds | 86 |
| dairy cattle | 85 |
| serum igg | 83 |
| confinement housing | 80 |
| dairy farms | 78 |
| bovine coronavirus | 75 |
| oocyst shedding | 74 |
| fecal samples | 74 |
| neonatal calf | 72 |
| healthy calves | 72 |
| calf health | 71 |
| faecal samples | 70 |
| united states | 69 |
| diarrhoeic calves | 69 |
| body weight | 68 |
| calf diarrhoea | 68 |
| immune system | 67 |
| dairy cows | 66 |
| factors associated | 62 |
| weight gain | 62 |
| treatment groups | 61 |
| cord uid | 59 |
| doc id | 59 |
| parvum infection | 59 |
| mg kg | 59 |
| fed calves | 59 |
| animal health | 59 |
| control calves | 59 |
| calf rearing | 58 |
| cryptosporidium species | 58 |
| oocyst excretion | 55 |
| health status | 55 |
| epithelial cells | 55 |
| igg concentrations | 55 |
| respiratory tract | 54 |
| beef calves | 53 |
| neonatal diarrhea | 52 |
| colostrum feeding | 52 |
| infected calves | 52 |
| animal welfare | 51 |
| per day | 50 |
| igg concentration | 49 |
| mortality rate | 49 |
| calf contact | 48 |
| control group | 48 |
| antimicrobial drugs | 47 |
| cryptosporidium sp | 47 |
| colostrum management | 46 |
| fluid therapy | 46 |
| holstein calves | 46 |
| risk assessment | 46 |
| dry matter | 44 |
| days old | 44 |
| weaned calves | 44 |
| previous studies | 44 |
| mortality rates | 43 |
| bovine viral | 43 |
| calves may | 43 |
| veal calf | 43 |
| preweaned calves | 43 |
| beef cattle | 42 |
| total protein | 42 |
| metabolic acidosis | 41 |
| first week | 41 |
| study period | 41 |
| experimental infection | 40 |
| current study | 40 |
| oxidative stress | 40 |
| mg ml | 40 |
| treated calves | 40 |
| calves housed | 40 |
| bovine colostrum | 39 |
| heifer calves | 39 |
| clinical disease | 39 |
| significant differences | 39 |
| gnotobiotic calves | 39 |
| first days | 38 |
| new zealand | 38 |
| otitis media | 38 |
| mycoplasma bovis | 38 |
| colostrum replacer | 38 |
| poor welfare | 38 |
| parvum oocysts | 37 |
| immune response | 37 |
| calf starter | 37 |
| infectious agents | 37 |
| dairy calf | 37 |
| significantly higher | 37 |
| fecal score | 36 |
| calves born | 36 |
| fecal dry | 36 |
| cryptosporidium baileyi | 36 |
| fed colostrum | 35 |
| milk replacers | 35 |
| molecular characterization | 35 |
| serum protein | 35 |
| fed milk | 35 |
| essential oil | 35 |
| waste milk | 35 |
| average daily | 34 |
| fecal scores | 34 |
| old calves | 34 |
| group pens | 34 |
| cryptosporidium oocysts | 33 |
| colostrum intake | 33 |
| intestinal tract | 33 |
| significantly lower | 33 |
| field trial | 33 |
| flaxseed oil | 33 |
| salmonella spp | 33 |
| oregano essential | 32 |
| dairy heifers | 32 |
| farm animals | 32 |
| salmonella typhimurium | 32 |
| blood samples | 32 |
| white veal | 32 |
| individual pens | 32 |
| age groups | 32 |
| gastrointestinal tract | 31 |
| calves received | 31 |
| food safety | 31 |
| significant difference | 31 |
| potential risk | 31 |
| farming systems | 31 |
| two different | 31 |
| increased risk | 31 |
| calf welfare | 31 |
| adult cattle | 31 |
| significantly associated | 31 |
| kg bw | 30 |
| plasma cortisol | 30 |
| bovine rotavirus | 30 |
| rotavirus infection | 30 |
| goat kids | 30 |
| may also | 30 |
| veterinary medicine | 30 |
| per gram | 29 |
| antimicrobial treatment | 29 |
| growth performance | 29 |
| viral diarrhea | 29 |
| milk production | 29 |
| ad libitum | 29 |
| dairy herd | 29 |
| transition milk | 29 |
| herd size | 29 |
| intestinal epithelial | 29 |
| fattening period | 29 |
| antimicrobial agents | 28 |
| dry period | 28 |
| ml kg | 28 |
| rumen development | 28 |
| one calf | 28 |
| calves kept | 28 |
| antimicrobial drug | 28 |
| first colostrum | 28 |
| swedish dairy | 28 |
| enteric pathogens | 28 |
| previously described | 27 |
| sample size | 27 |
| nsaid db | 27 |
| quality colostrum | 27 |
| per cent | 27 |
| total number | 27 |
| winter dysentery | 27 |
| working group | 27 |
| hypertonic saline | 27 |
| general condition | 27 |
| longitudinal study | 27 |
| performed using | 27 |
| twice daily | 26 |
| enteric disease | 26 |
| fecal shedding | 26 |
| housing calves | 26 |
| nasal swabs | 26 |
| sick calves | 26 |
| fatty acids | 26 |
| calves aged | 26 |
| neonatal dairy | 26 |
| field conditions | 26 |
| age group | 26 |
| risk factor | 25 |
| study ii | 25 |
| two calves | 25 |
| treatment group | 25 |
| mg dl | 25 |
| study i | 25 |
| four weeks | 25 |
| cattle herds | 25 |
| alfalfa hay | 25 |
| calves reared | 25 |
| antibody responses | 25 |
| experimentally infected | 25 |
| commercially available | 25 |
| rearing systems | 25 |
| housed calves | 25 |
| management factors | 25 |
| zoonotic transmission | 25 |
| naturally infected | 25 |
| veal herds | 25 |
| infected animals | 24 |
| per calf | 24 |
| trt calves | 24 |
| diarrhoea virus | 24 |
| colostral immunoglobulins | 24 |
| older calves | 24 |
| oocysts per | 24 |
| kg body | 24 |
| calves infected | 24 |
| neonatal diarrhoea | 24 |
| high mortality | 24 |
| unrewarded visits | 24 |
| infectious diseases | 23 |
| scoring system | 23 |
| box stall | 23 |
| dairy heifer | 23 |
| antimicrobial use | 23 |
| california dairies | 23 |
| public health | 23 |
| bull calves | 23 |
| calf pens | 23 |
| colostrum quality | 23 |
| calves treated | 23 |
| three calves | 23 |
| individual calf | 23 |
| rearing unit | 23 |
| jersey calves | 23 |
| hydrated lime | 23 |
| lying behavior | 23 |
| diarrheic calf | 23 |
| epithelial cell | 23 |
| milk feeding | 22 |
| production cycle | 22 |
| colostral immunoglobulin | 22 |
| first weeks | 22 |
| calf farming | 22 |
| giardia duodenalis | 22 |
| veal herd | 22 |
| small intestinal | 22 |
| three weeks | 22 |
| analyzed using | 22 |
| haemoglobin levels | 22 |
| immune responses | 22 |
| total serum | 22 |
| severe diarrhea | 22 |
| experimental infections | 22 |
| rectal temperature | 22 |
| enterotoxigenic escherichia | 22 |
| oral rehydration | 22 |
| positive samples | 22 |
| one study | 22 |
| colostral igg | 22 |
| septicemic calves | 21 |
| infrared thermography | 21 |
| relative abundance | 21 |
| calf herds | 21 |
| sodium bicarbonate | 21 |
| calf management | 21 |
| calf model | 21 |
| significantly different | 21 |
| beef herds | 21 |
| cryptosporidium isolates | 21 |
| faecal microbiota | 21 |
| body temperature | 21 |
| logistic regression | 21 |
| respiratory rate | 21 |
| state university | 21 |
| feeding colostrum | 21 |
| villous atrophy | 21 |
| economic losses | 21 |
| treatment rates | 21 |
| several studies | 21 |
| group housing | 21 |
| diarrhea virus | 21 |
| bcov infection | 21 |
| weeks old | 20 |
| bcov igg | 20 |
| systematic review | 20 |
| risk calves | 20 |
| igg ab | 20 |
| fecal microbiota | 20 |
| body condition | 20 |
| diarrhea problems | 20 |
| oral administration | 20 |
| ab titers | 20 |
| calves effects | 20 |
| dairy farm | 20 |
| statistically significant | 20 |
| large intestine | 20 |
| even though | 20 |
| two weeks | 20 |
| respiratory syncytial | 20 |
| viral rna | 20 |
| blood haemoglobin | 20 |
| room temperature | 20 |
| oral electrolyte | 20 |
| study design | 20 |
| colostrum fed | 19 |
| herd level | 19 |
| digestive tract | 19 |
| scientific veterinary | 19 |
| naturally occurring | 19 |
| coli isolates | 19 |
| eco group | 19 |
| calves within | 19 |
| odds ratio | 19 |
| calves showed | 19 |
| daily gain | 19 |
| drug use | 19 |
| fecal output | 19 |
| prepatent period | 19 |
| faecal consistency | 19 |
| within hours | 19 |
| nasal discharge | 19 |
| fecal consistency | 19 |
| hpn calves | 19 |
| commonly used | 19 |
| statistical analysis | 19 |
| bw gain | 19 |
| calves receiving | 19 |
| bcov rna | 19 |
| human cryptosporidiosis | 19 |
| cryptosporidial infection | 19 |
| antimicrobial resistance | 18 |
| breda virus | 18 |
| bovine torovirus | 18 |
| preweaned dairy | 18 |
| lactase activity | 18 |
| matter percentage | 18 |
| patent period | 18 |
| also reported | 18 |
| acute phase | 18 |
| different farms | 18 |
| scientific opinion | 18 |
| specific antibodies | 18 |
| box stalls | 18 |
| calves effect | 18 |
| syncytial virus | 18 |
| cr group | 18 |
| ng ml | 18 |
| intestinal epithelium | 18 |
| final model | 18 |
| total fecal | 18 |
| transmissible gastroenteritis | 17 |
| viral diarrhoea | 17 |
| bovine cryptosporidiosis | 17 |
| campylobacter spp | 17 |
| calves prevalence | 17 |
| new york | 17 |
| kg day | 17 |
| induction period | 17 |
| health management | 17 |
| incidence risk | 17 |
| milk allowance | 17 |
| newborn calf | 17 |
| maternal antibodies | 17 |
| growth rates | 17 |
| bovine virus | 17 |
| iron deficiency | 17 |
| farm management | 17 |
| immune function | 17 |
| direct contact | 17 |
| milk intake | 17 |
| jugular vein | 17 |
| least one | 17 |
| preweaning period | 17 |
| plasma concentrations | 17 |
| oil blend | 17 |
| maternal colostrum | 17 |
| calving season | 17 |
| serum total | 17 |
| calf cryptosporidiosis | 17 |
| milk fed | 17 |
| recent study | 17 |
| naturally acquired | 17 |
| calves per | 17 |
| calves date | 17 |
| calf production | 17 |
| respiratory pathogens | 17 |
| antibiotic resistance | 17 |
| individual calves | 17 |
| may occur | 17 |
| brush border | 17 |
| whole milk | 17 |
| fecal specimens | 17 |
| salmonella newport | 16 |
| respiratory infections | 16 |
| experimental calves | 16 |
| ff treatments | 16 |
| antimicrobial therapy | 16 |
| rrna gene | 16 |
| immunoglobulin absorption | 16 |
| mixed infections | 16 |
| colostrum within | 16 |
| study population | 16 |
| experimentally induced | 16 |
| recent studies | 16 |
| coli strains | 16 |
| heart rate | 16 |
| nested pcr | 16 |
| control pens | 16 |
| nasal secretions | 16 |
| another study | 16 |
| north america | 16 |
| control groups | 16 |
| maternity pen | 16 |
| mammary gland | 16 |
| mycobacterium avium | 16 |
| closely related | 16 |
| two groups | 16 |
| randomly assigned | 16 |
| antioxidative status | 16 |
| associated disease | 16 |
| animal care | 16 |
| disease control | 16 |
| clinical symptoms | 16 |
| previously reported | 16 |
| factors affecting | 16 |
| baileyi infection | 15 |
| clinical model | 15 |
| data collected | 15 |
| negative control | 15 |
| cfu ml | 15 |
| suckling calves | 15 |
| intestinal contents | 15 |
| relative abundances | 15 |
| study end | 15 |
| intestinal absorption | 15 |
| dairy cow | 15 |
| farmed animals | 15 |
| vaccinated cows | 15 |
| supplemented transition | 15 |
| gut microbiota | 15 |
| individual housing | 15 |
| among groups | 15 |
| pasteurized colostrum | 15 |
| eimeria bovis | 15 |
| feed efficiency | 15 |
| laboratory model | 15 |
| sas institute | 15 |
| growth rate | 15 |
| respiratory cryptosporidiosis | 15 |
| first month | 15 |
| phase proteins | 15 |
| parvum infections | 15 |
| foodborne pathogens | 15 |
| vaccinated calves | 15 |
| may result | 15 |
| regression model | 15 |
| feedlot cattle | 15 |
| calves less | 15 |
| feed intake | 15 |
| different species | 15 |
| cows vaccinated | 14 |
| milk substitute | 14 |
| older animals | 14 |
| among calves | 14 |
| authors declare | 14 |
| nasal swab | 14 |
| broiler chickens | 14 |
| fixed effects | 14 |
| california dairy | 14 |
| calves given | 14 |
| milk consumption | 14 |
| significantly reduced | 14 |
| protein concentration | 14 |
| bcv infection | 14 |
| per group | 14 |
| different types | 14 |
| space allowance | 14 |
| automatic milk | 14 |
| large number | 14 |
| dry cows | 14 |
| antibiotic treatment | 14 |
| wide range | 14 |
| data collection | 14 |
| fluids given | 14 |
| week old | 14 |
| hypertonic rehydration | 14 |
| pcr products | 14 |
| cryptosporidium meleagridis | 14 |
| calves presented | 14 |
| red deer | 14 |
| cryptosporidium infections | 14 |
| serum samples | 14 |
| first milking | 14 |
| upper respiratory | 14 |
| times per | 14 |
| calf housing | 14 |
| mg se | 14 |
| rice bran | 14 |
| esophageal feeder | 14 |
| stall calves | 14 |
| samples collected | 14 |
| electrolyte solutions | 14 |
| therapeutic group | 13 |
| electron microscopy | 13 |
| individual animal | 13 |
| randomly selected | 13 |
| water buffalo | 13 |
| experimental cryptosporidiosis | 13 |
| commonly found | 13 |
| treated group | 13 |
| ratio fish | 13 |
| reared calves | 13 |
| three times | 13 |
| exposure assessment | 13 |
| young dairy | 13 |
| early separation | 13 |
| amino acids | 13 |
| suckling reflex | 13 |
| inflammatory drug | 13 |
| rotavirus diarrhea | 13 |
| higher mortality | 13 |
| holstein bull | 13 |
| calves bovine | 13 |
| pain relief | 13 |
| stable enterotoxin | 13 |
| oocysts shed | 13 |
| first three | 13 |
| nervous system | 13 |
| cr calves | 13 |
| clostridium perfringens | 13 |
| multivariable model | 13 |
| blood cell | 13 |
| milk fever | 13 |
| per kg | 13 |
| bovis infection | 13 |
| trt group | 13 |
| abdominal pain | 13 |
| oral fluid | 13 |
| early detection | 13 |
| first wk | 13 |
| colostrum may | 13 |
| lpn calves | 13 |
| norwegian dairy | 13 |
| intestinal cryptosporidiosis | 13 |
| oregano oil | 13 |
| serum immunoglobulin | 13 |
| excreting oocysts | 13 |
| protective effect | 13 |
| daily weight | 13 |
| per farm | 13 |
| intestinal lumen | 13 |
| calves using | 13 |
| bicarbonate solution | 13 |
| bacterial contamination | 13 |
| infectious enteritis | 13 |
| friesian calves | 13 |
| small ruminants | 13 |
| pasteurized waste | 13 |
| dairy industry | 13 |
| community membership | 13 |
| veterinary committee | 13 |
| prophylactic use | 13 |
| solid feed | 13 |
| treatment records | 13 |
| environmental contamination | 13 |
| control animals | 13 |
| bacterial pathogens | 13 |
| consecutive days | 13 |
| dry feed | 13 |
| serum albumin | 13 |
| phylogenetic analysis | 13 |
| abomasal ulcers | 13 |
| electrolyte solution | 13 |
| individual hutches | 12 |
| beneficial effect | 12 |
| salmonella dublin | 12 |
| respiratory sounds | 12 |
| derived igg | 12 |
| model included | 12 |
| fed pasteurized | 12 |
| positive calves | 12 |
| data set | 12 |
| group pen | 12 |
| may cause | 12 |
| suckle reflex | 12 |
| housing systems | 12 |
| herd studies | 12 |
| clinical trial | 12 |
| two days | 12 |
| intestinal mucosa | 12 |
| experimental cryptosporidium | 12 |
| exact test | 12 |
| disease management | 12 |
| herd prevalence | 12 |
| lymph nodes | 12 |
| first months | 12 |
| institute inc | 12 |
| statistical analyses | 12 |
| shiga toxin | 12 |
| invited review | 12 |
| viral shedding | 12 |
| last years | 12 |
| milking cows | 12 |
| cryptosporidium muris | 12 |
| recovery period | 12 |
| air quality | 12 |
| repeated measures | 12 |
| husbandry systems | 12 |
| diagnostic laboratory | 12 |
| pl group | 12 |
| pasteurized milk | 12 |
| fecal sample | 12 |
| lying times | 12 |
| previous study | 12 |
| experimentally challenged | 12 |
| white blood | 12 |
| blend added | 12 |
| calves need | 12 |
| high incidence | 12 |
| metaphylactic treatment | 12 |
| monoclonal antibodies | 12 |
| clinical manifestations | 12 |
| medicated milk | 12 |
| natural infection | 12 |
| days post | 12 |
| mortality risk | 12 |
| pcr assay | 12 |
| birth weight | 12 |
| liquid feed | 12 |
| starter intake | 12 |
| colostral leukocytes | 12 |
| ff ml | 12 |
| adverse effects | 12 |
| molecular epidemiology | 12 |
| adequate passive | 12 |
| antibody titres | 12 |
| holstein cows | 12 |
| also found | 12 |
| described previously | 11 |
| results indicate | 11 |
| ig absorption | 11 |
| immune status | 11 |
| experimental studies | 11 |
| cell culture | 11 |
| nucleotide sequence | 11 |
| different calf | 11 |
| beef cows | 11 |
| posttreatment period | 11 |
| individually housed | 11 |
| western france | 11 |
| linked immunosorbent | 11 |
| oocyst counts | 11 |
| sampling day | 11 |
| high morbidity | 11 |
| intensive calf | 11 |
| life cycle | 11 |
| herd management | 11 |
| vaccinated animals | 11 |
| calf serum | 11 |
| hypertonic bicarbonate | 11 |
| drugs used | 11 |
| fecal culture | 11 |
| control cows | 11 |
| affected calves | 11 |
| coliform bacteria | 11 |
| feeding calves | 11 |
| log oocysts | 11 |
| colostral immunity | 11 |
| calves cryptosporidium | 11 |
| villus atrophy | 11 |
| welfare aspects | 11 |
| rotavirus infections | 11 |
| virus diarrhoea | 11 |
| fecal oocyst | 11 |
| dairy operations | 11 |
| monoclonal antibody | 11 |
| lamina propria | 11 |
| morning feeding | 11 |
| dairy science | 11 |
| commercial milk | 11 |
| disease complex | 11 |
| nonpasteurized milk | 11 |
| modified live | 11 |
| higher prevalence | 11 |
| enteric infections | 11 |
| health problems | 11 |
| management systems | 11 |
| personal communication | 11 |
| blood cultures | 11 |
| parenteral antimicrobial | 11 |
| herd health | 11 |
| calves raised | 11 |
| clinically ill | 11 |
| full dose | 11 |
| high prevalence | 11 |
| geometric mean | 11 |
| housed individually | 11 |
| farm visit | 11 |
| nonsepticemic calves | 11 |
| eimeria spp | 11 |
| significant association | 11 |
| welfare section | 11 |
| saleable milk | 11 |
| risk analysis | 11 |
| udder health | 11 |
| calf separation | 11 |
| neutralizing antibodies | 11 |
| local anesthetic | 11 |
| sequence analysis | 11 |
| animal species | 11 |
| reactive oxygen | 11 |
| calf hutches | 11 |
| became infected | 11 |
| authors thank | 11 |
| feeding behavior | 11 |
| disease prevention | 11 |
| mammary secretions | 11 |
| determine whether | 11 |
| van weeren | 11 |
| individual pen | 11 |
| ic samples | 11 |
| genotype ii | 11 |
| considered significant | 11 |
| respiratory diseases | 11 |
| bvdv infection | 11 |
| calf houses | 11 |
| health monitoring | 11 |
| diarrhea caused | 11 |
| social contact | 11 |
| yeast species | 11 |
| restricted suckling | 11 |
| oral fluids | 11 |
| weight loss | 11 |
| companion animals | 11 |
| overall mortality | 11 |
| level risk | 11 |
| se head | 11 |
| calf pneumonia | 11 |
| strains isolated | 11 |
| air space | 11 |
| passive protection | 11 |
| also important | 10 |
| oxygen species | 10 |
| important cause | 10 |
| egg yolk | 10 |
| associated risk | 10 |
| within minutes | 10 |
| producing escherichia | 10 |
| successfully treated | 10 |
| balf samples | 10 |
| antibiotic use | 10 |
| sodium chloride | 10 |
| large amounts | 10 |
| three months | 10 |
| independent variables | 10 |
| cryptosporidium bovis | 10 |
| highest prevalence | 10 |
| treatment failures | 10 |
| gi tract | 10 |
| negative effect | 10 |
| dietary changes | 10 |
| replacer fed | 10 |
| linear mixed | 10 |
| first moderate | 10 |
| serum ig | 10 |
| protein levels | 10 |
| different farming | 10 |
| bovine rva | 10 |
| calves tested | 10 |
| fatty acid | 10 |
| isolation rate | 10 |
| immunoglobulin concentrations | 10 |
| fermented milk | 10 |
| united kingdom | 10 |
| therapeutic use | 10 |
| fed groups | 10 |
| eimeria zuernii | 10 |
| giardia spp | 10 |
| bedding material | 10 |
| feeding systems | 10 |
| time points | 10 |
| serum concentrations | 10 |
| beef cow | 10 |
| growth factors | 10 |
| initial treatment | 10 |
| bred heifers | 10 |
| clinical scores | 10 |
| cryptosporidium genotypes | 10 |
| future research | 10 |
| heat stress | 10 |
| early age | 10 |
| severe diarrhoea | 10 |
| bovine neonates | 10 |
| cortisol levels | 10 |
| supportive care | 10 |
| intraruminal administration | 10 |
| regression models | 10 |
| higher risk | 10 |
| zoonotic potential | 10 |
| statistical software | 10 |
| lactogenic immunity | 10 |
| less likely | 10 |
| per animal | 10 |
| commercial dairy | 10 |
| protective immunity | 10 |
| conducted using | 10 |
| serum biochemical | 10 |
| molecular methods | 10 |
| milk solids | 10 |
| natural cryptosporidiosis | 10 |
| clinical illness | 10 |
| physical examination | 10 |
| table i | 10 |
| coli heat | 10 |
| head daily | 10 |
| cell loss | 10 |
| induced diarrhea | 10 |
| salt poisoning | 10 |
| around weaning | 10 |
| five days | 10 |
| villus length | 10 |
| mucous membranes | 10 |
| haemoglobin concentration | 10 |
| pregnant cows | 10 |
| untreated calves | 10 |
| calf performance | 10 |
| srb calves | 10 |
| mannheimia haemolytica | 10 |
| adult cows | 10 |
| tissue samples | 10 |
| experimental groups | 10 |
| colostrum replacement | 10 |
| adult dairy | 10 |
| mean age | 10 |
| avium ssp | 10 |
| high risk | 10 |
| enteric nervous | 10 |
| four calves | 10 |
| nasal colonization | 10 |
| increased respiratory | 10 |
| six calves | 10 |
| rearing calves | 10 |
| solid feeds | 10 |
| poor growth | 10 |
| first feeding | 10 |
| feeding pasteurized | 10 |
| local anaesthesia | 10 |
| humoral immunity | 10 |
| blood culture | 10 |
| sufficient colostrum | 10 |
| lower mortality | 10 |
| diarrhea syndrome | 10 |
| calving pen | 10 |
| clinical examination | 10 |
| treatment protocol | 10 |
| reduced growth | 9 |
| agents associated | 9 |
| holstein herds | 9 |
| dietary groups | 9 |
| last four | 9 |
| se supplementation | 9 |
| ap activity | 9 |
| calf farms | 9 |
| factors contributing | 9 |
| four herds | 9 |
| suckling systems | 9 |
| odds ratios | 9 |
| orally administered | 9 |
| med doi | 9 |
| bovine serum | 9 |
| hemorrhagic shock | 9 |
| microscopic lesions | 9 |
| significantly increased | 9 |
| mixed model | 9 |
| chain reaction | 9 |
| also observed | 9 |
| slatted floors | 9 |
| rewarded visits | 9 |
| calculated using | 9 |
| viral infections | 9 |
| days later | 9 |
| radial immunodiffusion | 9 |
| crypt epithelium | 9 |
| significant effect | 9 |
| calves shed | 9 |
| brd prevalence | 9 |
| dutch dairy | 9 |
| predictive value | 9 |
| calves will | 9 |
| protein concentrations | 9 |
| like genotype | 9 |
| institutional animal | 9 |
| management program | 9 |
| respiratory disorders | 9 |
| three groups | 9 |
| showed signs | 9 |
| pasteurella multocida | 9 |
| electron microscopic | 9 |
| calves evaluation | 9 |
| cryptosporidial oocysts | 9 |
| immunoglobulin concentration | 9 |
| effective treatment | 9 |
| calves suffering | 9 |
| therapeutic mabs | 9 |
| antimicrobial susceptibility | 9 |
| studies conducted | 9 |
| faecal prevalence | 9 |
| determined using | 9 |
| replacement heifers | 9 |
| immunosorbent assay | 9 |
| study calves | 9 |
| intestinal motility | 9 |
| colostrum ingestion | 9 |
| farm level | 9 |
| severe metabolic | 9 |
| farmed deer | 9 |
| cryptosporidium positive | 9 |
| nucleotide sequences | 9 |
| lime disinfected | 9 |
| chicken egg | 9 |
| calves comparison | 9 |
| diarrhea due | 9 |
| may increase | 9 |
| calves died | 9 |
| biochemical parameters | 9 |
| measured using | 9 |
| production animals | 9 |
| serum amyloid | 9 |
| several factors | 9 |
| se concentrations | 9 |
| predictive values | 9 |
| cryptosporidium andersoni | 9 |
| virus isolation | 9 |
| passive immune | 9 |
| three experimental | 9 |
| given intravenously | 9 |
| condition score | 9 |
| treated groups | 9 |
| one week | 9 |
| db calves | 9 |
| reference lists | 9 |
| lys activity | 9 |
| keverling buisman | 9 |
| relatively low | 9 |
| confidence interval | 9 |
| pathogenic species | 9 |
| cryptosporidium hominis | 9 |
| parvum oocyst | 9 |
| intravenous fluid | 9 |
| calves shedding | 9 |
| calves experimentally | 9 |
| plasma volume | 9 |
| one hundred | 9 |
| human rotavirus | 9 |
| natural infections | 9 |
| fluid secretion | 9 |
| adaptive immune | 9 |
| large numbers | 9 |
| maternally derived | 9 |
| specific antibody | 9 |
| nutritive sucking | 9 |
| peracetic acid | 9 |
| carbon dioxide | 9 |
| factors related | 9 |
| samples taken | 9 |
| adequate transfer | 9 |
| use committee | 9 |
| enzyme activities | 9 |
| positive effect | 9 |
| antibody response | 9 |
| intracellular calcium | 9 |
| calves efficacy | 9 |
| growth factor | 9 |
| calf scours | 9 |
| production systems | 9 |
| calves receive | 9 |
| clinical efficacy | 9 |
| high levels | 9 |
| herd owners | 9 |
| day old | 9 |
| bos taurus | 9 |
| steroidal anti | 9 |
| calf faeces | 9 |
| increased mortality | 9 |
| primarily infected | 9 |
| gut closure | 9 |
| vaccinated herd | 9 |
| cohort study | 9 |
| housing conditions | 9 |
| oral behaviours | 9 |
| pathological changes | 9 |
| calves spent | 9 |
| postweaning weight | 9 |
| council directive | 9 |
| total solids | 9 |
| turbidity test | 9 |
| tested positive | 9 |
| group received | 9 |
| diarrheic feces | 9 |
| data obtained | 9 |
| enteropathogenic escherichia | 9 |
| significantly greater | 8 |
| greater risk | 8 |
| pink veal | 8 |
| approximately days | 8 |
| calves left | 8 |
| fed nonpasteurized | 8 |
| necrosis factor | 8 |
| antibody titers | 8 |
| higher levels | 8 |
| solid food | 8 |
| salmonella enterica | 8 |
| evaluated using | 8 |
| secretory diarrhea | 8 |
| found positive | 8 |
| rearing facility | 8 |
| susceptibility testing | 8 |
| virus infection | 8 |
| flunixin meglumine | 8 |
| species identification | 8 |
| giardia infections | 8 |
| safety implications | 8 |
| maternity pens | 8 |
| pig genotype | 8 |
| inadequate colostrum | 8 |
| absorptive capacity | 8 |
| pen design | 8 |
| systemic signs | 8 |
| control study | 8 |
| nonsteroidal anti | 8 |
| haemoglobin level | 8 |
| coronavirus infection | 8 |
| study identified | 8 |
| alimentary tract | 8 |
| probability cutoff | 8 |
| sodium concentrations | 8 |
| coronavirus infections | 8 |
| calving area | 8 |
| times higher | 8 |
| pens huts | 8 |
| standard deviation | 8 |
| mycobacterium bovis | 8 |
| calves consumed | 8 |
| veal production | 8 |
| female calves | 8 |
| one herd | 8 |
| colostrum supplementation | 8 |
| therapeutic efficacy | 8 |
| cause diarrhea | 8 |
| evidence suggests | 8 |
| scientific committee | 8 |
| second week | 8 |
| tract disease | 8 |
| controlled study | 8 |
| accession numbers | 8 |
| first report | 8 |
| rehydration solution | 8 |
| calves usually | 8 |
| calves exhibited | 8 |
| beneficial effects | 8 |
| severely dehydrated | 8 |
| block design | 8 |
| fed either | 8 |
| concurrent infections | 8 |
| macconkey agar | 8 |
| commonly reported | 8 |
| igm concentrations | 8 |
| cent dehydrated | 8 |
| species distribution | 8 |
| luminal ph | 8 |
| given subcutaneously | 8 |
| lactate treatment | 8 |
| categorical variables | 8 |
| shedding oocysts | 8 |
| low level | 8 |
| weaned dairy | 8 |
| colostrum supplements | 8 |
| immunity transfer | 8 |
| previous svc | 8 |
| first two | 8 |
| hydration status | 8 |
| buffered saline | 8 |
| dummy nipple | 8 |
| hygienic measures | 8 |
| veterinary diagnostic | 8 |
| alkaline phosphatase | 8 |
| outcome variables | 8 |
| clinically healthy | 8 |
| field study | 8 |
| published data | 8 |
| wood shavings | 8 |
| microbial communities | 8 |
| diarrhea associated | 8 |
| may lead | 8 |
| experimental design | 8 |
| study showed | 8 |
| infectious causes | 8 |
| randomized controlled | 8 |
| diarrheic dairy | 8 |
| born alive | 8 |
| social behaviour | 8 |
| gene expression | 8 |
| infection occurs | 8 |
| intestinal cells | 8 |
| milk yield | 8 |
| vp gene | 8 |
| vaccination status | 8 |
| colostrum using | 8 |
| descriptive statistics | 8 |
| ova concentrations | 8 |
| intestinal microbiota | 8 |
| calves also | 8 |
| treatment effect | 8 |
| also used | 8 |
| housing system | 8 |
| five calves | 8 |
| previous report | 8 |
| disease status | 8 |
| mixed procedure | 8 |
| organic dairy | 8 |
| science doi | 8 |
| nitric oxide | 8 |
| recent research | 8 |
| collected data | 8 |
| study also | 8 |
| hygiene measures | 8 |
| saline solution | 8 |
| linoleic acid | 8 |
| negatively associated | 8 |
| villous epithelium | 8 |
| results suggest | 8 |
| diarrhea cases | 8 |
| bubalus bubalis | 8 |
| abnormal oral | 8 |
| high amounts | 8 |
| maternal immunity | 8 |
| intravenous fluids | 8 |
| dependent variable | 8 |
| dry food | 8 |
| environmental conditions | 8 |
| administered orally | 8 |
| molecular characterisation | 8 |
| fixed factors | 8 |
| may differ | 8 |
| different age | 8 |
| granite fines | 8 |
| young animals | 8 |
| dichotomous variables | 8 |
| deprived calves | 8 |
| thermophilic campylobacter | 8 |
| human pathogenic | 8 |
| avian cryptosporidiosis | 8 |
| fpt group | 8 |
| amino acid | 8 |
| plasma glucose | 8 |
| calves older | 8 |
| clinical score | 8 |
| excreted oocysts | 8 |
| groups using | 8 |
| cfc samples | 8 |
| calf died | 8 |
| using two | 8 |
| invasive stages | 8 |
| least squares | 8 |
| may require | 8 |
| see table | 8 |
| domestic animals | 8 |
| health outcomes | 8 |
| vaccination programs | 8 |
| commercial vaccines | 8 |
| mean log | 8 |
| younger calves | 8 |
| common cause | 8 |
| new animals | 8 |
| calves compared | 8 |
| giardia intestinalis | 8 |
| shed oocysts | 8 |
| calf barns | 8 |
| acute undifferentiated | 8 |
| polymerase chain | 8 |
| commercial calf | 8 |
| infection may | 8 |
| higher serum | 8 |
| infectious bovine | 8 |
| rva strains | 8 |
| test results | 7 |
| time lying | 7 |
| small number | 7 |
| european union | 7 |
| igg abs | 7 |
| significant increase | 7 |
| bovine parainfluenza | 7 |
| danish cattle | 7 |
| abomasal emptying | 7 |
| important risk | 7 |
| potassium dichromate | 7 |
| quercetin aglycone | 7 |
| calves excreting | 7 |
| veterinary students | 7 |
| ae mm | 7 |
| challenged neonatal | 7 |
| six months | 7 |
| assessed using | 7 |
| antioxidative capacity | 7 |
| two herds | 7 |
| observational study | 7 |
| may affect | 7 |
| bovine enteric | 7 |
| blood agar | 7 |
| fattening units | 7 |
| infectious disease | 7 |
| normally distributed | 7 |
| daily health | 7 |
| calf barn | 7 |
| farmed rabbits | 7 |
| farm personnel | 7 |
| table ii | 7 |
| trial sites | 7 |
| specific igy | 7 |
| final multivariable | 7 |
| wheat straw | 7 |
| host range | 7 |
| passive immunization | 7 |
| clinical cryptosporidiosis | 7 |
| lagoon water | 7 |
| local anesthesia | 7 |
| artificially reared | 7 |
| different biotypes | 7 |
| human health | 7 |
| western canada | 7 |
| reference strain | 7 |
| calves developed | 7 |
| subtype iiaa | 7 |
| group showed | 7 |
| cattle industry | 7 |
| epidemiological studies | 7 |
| large dairy | 7 |
| ph level | 7 |
| adjuvanted rotavirus | 7 |
| feeding frequency | 7 |
| untreated control | 7 |
| focal infection | 7 |
| etec diarrhea | 7 |
| similar results | 7 |
| ml igg | 7 |
| eimeria species | 7 |
| first hours | 7 |
| selection criteria | 7 |
| like agent | 7 |
| sectional study | 7 |
| associated calf | 7 |
| young cattle | 7 |
| heart girth | 7 |
| gold standard | 7 |
| colostrum igg | 7 |
| ethics committee | 7 |
| urea nitrogen | 7 |
| calves included | 7 |
| main foodborne | 7 |
| acute pain | 7 |
| study herds | 7 |
| calf received | 7 |
| water station | 7 |
| common species | 7 |
| young stock | 7 |
| old animals | 7 |
| protozoan parasites | 7 |
| veal meat | 7 |
| animal husbandry | 7 |
| animal houses | 7 |
| average number | 7 |
| enteric lesions | 7 |
| cautery disbudding | 7 |
| respiratory acidosis | 7 |
| bronchoalveolar fluid | 7 |
| group compared | 7 |
| left untreated | 7 |
| negative impact | 7 |
| statistical significance | 7 |
| immune transfer | 7 |
| research centre | 7 |
| either individual | 7 |
| major cause | 7 |
| blood loss | 7 |
| epidemiological study | 7 |
| calf treatment | 7 |
| sentinel calves | 7 |
| standard operating | 7 |
| may contribute | 7 |
| reactive protein | 7 |
| vaccine placebo | 7 |
| data analysis | 7 |
| mobile phase | 7 |
| flow rate | 7 |
| replacer per | 7 |
| per production | 7 |
| generalized estimating | 7 |
| parvum subtype | 7 |
| higher odds | 7 |
| iron supply | 7 |
| important factor | 7 |
| negative predictive | 7 |
| sucking behaviour | 7 |
| serum half | 7 |
| faecal score | 7 |
| lower respiratory | 7 |
| innate immune | 7 |
| respiratory syncytical | 7 |
| czech republic | 7 |
| active immunity | 7 |
| factors influencing | 7 |
| cryptosporidium pig | 7 |
| study reported | 7 |
| disease may | 7 |
| clinical practice | 7 |
| study conducted | 7 |
| general linear | 7 |
| igg absorption | 7 |
| oxidant status | 7 |
| animal models | 7 |
| enrolled calves | 7 |
| mineral supplement | 7 |
| fa concentrations | 7 |
| growth promoters | 7 |
| neonatal immune | 7 |
| stall housing | 7 |
| respiratory health | 7 |
| calves excreted | 7 |
| stabilized rice | 7 |
| inclusion criteria | 7 |
| received colostrum | 7 |
| enteric coronavirus | 7 |
| one farm | 7 |
| calves influence | 7 |
| infective particles | 7 |
| jersey cows | 7 |
| important factors | 7 |
| mean number | 7 |
| hypertonic solutions | 7 |
| positive predictive | 7 |
| lying area | 7 |
| drinking water | 7 |
| bacterial infections | 7 |
| productivity study | 7 |
| surface area | 7 |
| nucleic acid | 7 |
| ventilation rates | 7 |
| different amounts | 7 |
| rice hulls | 7 |
| causative agent | 7 |
| colostrum collected | 7 |
| systemic illness | 7 |
| diarrhoea syndrome | 7 |
| antibiotic therapy | 7 |
| associated diarrhea | 7 |
| data loggers | 7 |
| holstein friesian | 7 |
| dominant species | 7 |
| took place | 7 |
| two dairy | 7 |
| buffalo calves | 7 |
| parainfluenza virus | 7 |
| small groups | 7 |
| relatively high | 7 |
| wooden hutches | 7 |
| feed calves | 7 |
| slatted floor | 7 |
| cattle health | 7 |
| also considered | 7 |
| rotavirus vaccine | 7 |
| first treatment | 7 |
| particle size | 7 |
| colostral derived | 7 |
| national animal | 7 |
| transmission electron | 7 |
| clinical significance | 7 |
| antibody products | 7 |
| daily administration | 7 |
| toxic changes | 7 |
| vaccinated dams | 7 |
| clinical relevance | 7 |
| svc report | 7 |
| human intestinal | 7 |
| published studies | 7 |
| drug therapy | 7 |
| disease virus | 7 |
| calf level | 7 |
| syncytical virus | 7 |
| humoral immune | 7 |
| struthio camelus | 7 |
| conventionally reared | 7 |
| meat quality | 7 |
| tp calves | 7 |
| time rt | 7 |
| sodium absorption | 7 |
| less time | 7 |
| calf feeding | 7 |
| rectal temperatures | 7 |
| health problem | 7 |
| corona virus | 7 |
| median amount | 7 |
| plasma ph | 7 |
| individual crates | 7 |
| oocysts excreted | 7 |
| standard curve | 7 |
| crypt hyperplasia | 7 |
| us dairy | 7 |
| diarrhea score | 7 |
| chronic rd | 7 |
| tumor necrosis | 7 |
| infectious agent | 7 |
| younger animals | 7 |
| calves became | 7 |
| york state | 7 |
| dm basis | 7 |
| different management | 7 |
| bovine herpesvirus | 7 |
| large groups | 7 |
| will also | 7 |
| lime disinfection | 7 |
| ahaw panel | 7 |
| economic impact | 7 |
| phospholipid fa | 7 |
| newborn dairy | 7 |
| clostridium difficile | 7 |
| straw bedding | 7 |
| consistency scores | 7 |
| contributing factors | 7 |
| recent data | 7 |
| colleagues reported | 7 |
| mean plasma | 7 |
| diarrhea may | 7 |
| previous reports | 7 |
| genotypes i | 7 |
| whole blood | 7 |
| mrna expression | 6 |
| rva diarrhea | 6 |
| organic certified | 6 |
| unpublished data | 6 |
| respiratory infection | 6 |
| salmonella infection | 6 |
| given parenterally | 6 |
| scientific report | 6 |
| individual animals | 6 |
| unvaccinated herd | 6 |
| possible food | 6 |
| vax calves | 6 |
| human patients | 6 |
| least two | 6 |
| replacer diet | 6 |
| included articles | 6 |
| serum creatinine | 6 |
| feeding programs | 6 |
| milk feeders | 6 |
| values obtained | 6 |
| raw colostrum | 6 |
| short communication | 6 |
| geographic distribution | 6 |
| various segments | 6 |
| solid foods | 6 |
| calves whose | 6 |
| colostrum administration | 6 |
| uc davis | 6 |
| colostral ig | 6 |
| fetal membranes | 6 |
| secretory response | 6 |
| ig concentrations | 6 |
| increased morbidity | 6 |
| groups within | 6 |
| lactic acidosis | 6 |
| group nv | 6 |
| infected cells | 6 |
| shedding bcov | 6 |
| study indicated | 6 |
| late gestation | 6 |
| cryptosporidiosis associated | 6 |
| provide evidence | 6 |
| inoculated onto | 6 |
| community structure | 6 |
| independent variable | 6 |
| transmission potential | 6 |
| lower odds | 6 |
| week period | 6 |
| log vrc | 6 |
| dynamic clinical | 6 |
| milk antibody | 6 |
| food animal | 6 |
| disease incidence | 6 |
| serum ova | 6 |
| predict septicemia | 6 |
| lymphocyte ratio | 6 |
| diarrhea onset | 6 |
| complete data | 6 |
| young calf | 6 |
| exposed group | 6 |
| gastrointestinal disorders | 6 |
| clinical findings | 6 |
| gentle contacts | 6 |
| preweaned heifer | 6 |
| control measures | 6 |
| eg calves | 6 |
| type i | 6 |
| morbidity due | 6 |
| effective method | 6 |
| digestive disorders | 6 |
| model risk | 6 |
| persistently infected | 6 |
| livestock buildings | 6 |
| fluid losses | 6 |
| oil administration | 6 |
| pathogenic bacteria | 6 |
| versus calves | 6 |
| incubated overnight | 6 |
| two species | 6 |
| animal handling | 6 |
| heat stable | 6 |
| eight calves | 6 |
| within days | 6 |
| neonatal pigs | 6 |
| made available | 6 |
| producers treated | 6 |
| igg seroconversion | 6 |
| unvaccinated controls | 6 |
| pasteurised milk | 6 |
| detection limit | 6 |
| animal diseases | 6 |
| longer prepatent | 6 |
| experimental study | 6 |
| infectious organisms | 6 |
| primary pathogen | 6 |
| first day | 6 |
| mycoplasmal disease | 6 |
| kg per | 6 |
| identified cryptosporidium | 6 |
| physiological changes | 6 |
| watery faeces | 6 |
| winter months | 6 |
| fisher scientific | 6 |
| limited number | 6 |
| detection rate | 6 |
| calf losses | 6 |
| viral agents | 6 |
| bovine igg | 6 |
| study personnel | 6 |
| pathogenic coccidia | 6 |
| strong ion | 6 |
| metal hutches | 6 |
| randomly allocated | 6 |
| evacuated tubes | 6 |
| hypersensitivity reactions | 6 |
| agar plates | 6 |
| zinc sulfate | 6 |
| rehydration therapy | 6 |
| fluid intake | 6 |
| cr products | 6 |
| fecal iga | 6 |
| disinfected pens | 6 |
| foodborne hazards | 6 |
| polyunsaturated fatty | 6 |
| replacer feeding | 6 |
| high calf | 6 |
| calving records | 6 |
| management conditions | 6 |
| calf respiratory | 6 |
| bovine rhinotracheitis | 6 |
| diarrhoeal problems | 6 |
| provide passive | 6 |
| group size | 6 |
| survival curves | 6 |
| multivariable analysis | 6 |
| groove reflex | 6 |
| passively acquired | 6 |
| time point | 6 |
| primary reason | 6 |
| secondary bacterial | 6 |
| avium subsp | 6 |
| brd outbreak | 6 |
| holstein heifers | 6 |
| bovis bacterin | 6 |
| glucose metabolism | 6 |
| squares means | 6 |
| creatinine concentration | 6 |
| without diarrhea | 6 |
| newport bacterin | 6 |
| milk versus | 6 |
| colostral antibodies | 6 |
| dually infected | 6 |
| higher incidence | 6 |
| different ages | 6 |
| colony morphology | 6 |
| plasma cells | 6 |
| true positive | 6 |
| immune factors | 6 |
| treating calves | 6 |
| virus replication | 6 |
| per dose | 6 |
| interquartile range | 6 |
| zoonotic cryptosporidiosis | 6 |
| quantitative food | 6 |
| management system | 6 |
| higher adg | 6 |
| intestinal lesions | 6 |
| affected animals | 6 |
| calf experimental | 6 |
| verotoxigenic escherichia | 6 |
| tract infections | 6 |
| developing countries | 6 |
| prophylactic treatment | 6 |
| well understood | 6 |
| endemically infected | 6 |
| method used | 6 |
| sum test | 6 |
| calf immunity | 6 |
| necropsy findings | 6 |
| liquid diarrhoea | 6 |
| oral behaviors | 6 |
| feeding regimen | 6 |
| specific serum | 6 |
| bovine plasma | 6 |
| linear regression | 6 |
| bottle feeding | 6 |
| three different | 6 |
| immunoglobulin transfer | 6 |
| producing animals | 6 |
| dna extraction | 6 |
| intensively reared | 6 |
| bethyl laboratories | 6 |
| behavioural points | 6 |
| every day | 6 |
| srb group | 6 |
| heifer calf | 6 |
| first identified | 6 |
| behavioral changes | 6 |
| studies reported | 6 |
| vet med | 6 |
| different rearing | 6 |
| cryptosporidium oocyst | 6 |
| bovine milk | 6 |
| antibody transfer | 6 |
| time spent | 6 |
| igg serum | 6 |
| mucosal surface | 6 |
| also identified | 6 |
| colostrum samples | 6 |
| oxylipid concentrations | 6 |
| inflammatory cytokines | 6 |
| dairy producers | 6 |
| mean serum | 6 |
| apt group | 6 |
| disease severity | 6 |
| time interaction | 6 |
| well established | 6 |
| oocyst numbers | 6 |
| rotaviral diarrhea | 6 |
| potential pathogens | 6 |
| high air | 6 |
| southern ontario | 6 |
| morbidity rates | 6 |
| mouth disease | 6 |
| daily opg | 6 |
| transfer status | 6 |
| replacer nutrition | 6 |
| ruminal drinking | 6 |
| born calves | 6 |
| proximal small | 6 |
| affects calves | 6 |
| veterinary clinics | 6 |
| calf per | 6 |
| border enzyme | 6 |
| edward island | 6 |
| many countries | 6 |
| median adg | 6 |
| placebo calves | 6 |
| supplemented calves | 6 |
| dry cow | 6 |
| secretory iga | 6 |
| calves required | 6 |
| study may | 6 |
| disease organisms | 6 |
| north american | 6 |
| sham calves | 6 |
| studies using | 6 |
| holstein dairy | 6 |
| farm animal | 6 |
| causing diarrhoea | 6 |
| may vary | 6 |
| prince edward | 6 |
| results indicated | 6 |
| animal production | 6 |
| pain associated | 6 |
| ae days | 6 |
| parvum shedding | 6 |
| human medicine | 6 |
| factors may | 6 |
| observation period | 6 |
| member states | 6 |
| rotavirus strains | 6 |
| serum cortisol | 6 |
| canada geese | 6 |
| previous findings | 6 |
| positive animals | 6 |
| rotavirus serotypes | 6 |
| calving environment | 6 |
| housed dairy | 6 |
| veterinary services | 6 |
| cart model | 6 |
| western canadian | 6 |
| become infected | 6 |
| fa supplementation | 6 |
| predisposing factors | 6 |
| surface water | 6 |
| weaned piglets | 6 |
| reasonably well | 6 |
| goose genotypes | 6 |
| large molecules | 6 |
| approximately weeks | 6 |
| studies i | 6 |
| low serum | 6 |
| vaccination protocol | 6 |
| milk powder | 6 |
| veterinary use | 6 |
| authors also | 6 |
| automated measures | 6 |
| rank sum | 6 |
| without diarrhoea | 6 |
| neonatal ruminants | 6 |
| colostrum antibodies | 6 |
| bacterial taxa | 6 |
| nutrient requirements | 6 |
| infected neonatal | 6 |
| preweaned heifers | 6 |
| lower incidence | 6 |
| successful passive | 6 |
| four times | 6 |
| igg levels | 6 |
| mycoplasma spp | 6 |
| german dairy | 6 |
| low sensitivity | 6 |
| given orally | 6 |
| authors concluded | 6 |
| pathogens associated | 6 |
| developed diarrhoea | 6 |
| maternal vaccination | 6 |
| subclinical infection | 6 |
| mediated immunity | 6 |
| mixed models | 6 |
| blood plasma | 6 |
| atrophic villi | 6 |
| relative humidity | 6 |
| veterinary vaccines | 6 |
| ammonia concentrations | 6 |
| weight data | 6 |
| clinical examinations | 6 |
| abomasal luminal | 6 |
| bcov shedding | 6 |
| calf house | 6 |
| antibacterial treatment | 6 |
| faecal shedding | 6 |
| various factors | 6 |
| parvum subtypes | 6 |
| south america | 6 |
| hazard characterisation | 6 |
| mg per | 6 |
| immunologic patterns | 6 |
| least days | 6 |
| oral vaccination | 6 |
| preruminant calves | 6 |
| egg antibodies | 6 |
| summer months | 6 |
| endocrine traits | 6 |
| without pain | 6 |
| well plate | 6 |
| calf infected | 6 |
| symptomatic calves | 6 |
| artificial rearing | 6 |
| clinical coccidiosis | 6 |
| several days | 6 |
| calves around | 6 |
| mean daily | 6 |
| southern britain | 6 |
| wilcoxon rank | 6 |
| infection rates | 6 |
| losses associated | 6 |
| replacer powder | 6 |
| analysis revealed | 6 |
| extracellular fluid | 6 |
| bovine immunoglobulins | 6 |
| higher body | 6 |
| diarrhoea caused | 6 |
| dichotomous variable | 6 |
| food animals | 6 |
| high quality | 6 |
| low levels | 6 |
| several weeks | 6 |
| pathological findings | 6 |
| multifactorial disease | 6 |
| plasma transfusion | 6 |
| lacteal secretions | 6 |
| atopic dermatitis | 6 |
| automatic feeding | 6 |
| may influence | 6 |
| ctr calves | 6 |
| studies found | 6 |
| treatment protocols | 6 |
| stool sample | 6 |
| different methods | 6 |
| random effect | 6 |
| feeding system | 6 |
| serum antibody | 6 |
| stocking density | 6 |
| per sample | 6 |
| enteric viral | 6 |
| predictive ability | 6 |
| first four | 6 |
| long wheat | 6 |
| calf ranch | 6 |
| calf heifers | 6 |
| cryptosporidium prevalence | 6 |
| normal feces | 6 |
| water content | 6 |
| hutches made | 5 |
| live weight | 5 |
| research facility | 5 |
| first six | 5 |
| study demonstrated | 5 |
| esophageal groove | 5 |
| supplement containing | 5 |
| internal parasites | 5 |
| herd investigation | 5 |
| calf growth | 5 |
| fed greater | 5 |
| calves reported | 5 |
| bovine coccidiosis | 5 |
| quality control | 5 |
| different pathogens | 5 |
| health assessment | 5 |
| median percent | 5 |
| milking colostrum | 5 |
| bovis infections | 5 |
| gut flora | 5 |
| calves younger | 5 |
| applied biosystems | 5 |
| two treatment | 5 |
| longer period | 5 |
| maize silage | 5 |
| previous exposure | 5 |
| significantly affected | 5 |
| colostrum supplement | 5 |
| base status | 5 |
| logit link | 5 |
| diseased animals | 5 |
| unvaccinated herds | 5 |
| housed veal | 5 |
| parvum gp | 5 |
| peripheral blood | 5 |
| among dairy | 5 |
| housing type | 5 |
| major problem | 5 |
| automatic feeder | 5 |
| calf diarrhoeal | 5 |
| milk protein | 5 |
| concentrates consumed | 5 |
| fluid administration | 5 |
| chicks inoculated | 5 |
| mortem examination | 5 |
| epithelium may | 5 |
| juvenile ruminants | 5 |
| urine production | 5 |
| like particle | 5 |
| mean total | 5 |
| nine calves | 5 |
| lactating cows | 5 |
| calf diseases | 5 |
| drug administration | 5 |
| following vaccination | 5 |
| anim pract | 5 |
| dry weight | 5 |
| assessment approach | 5 |
| faecal suspension | 5 |
| bacterial overgrowth | 5 |
| kda glycoprotein | 5 |
| receiver calves | 5 |
| four isolates | 5 |
| associated management | 5 |
| calves mainly | 5 |
| higher milk | 5 |
| antibiotic residues | 5 |
| may become | 5 |
| phosphate buffer | 5 |
| virus shedding | 5 |
| animal science | 5 |
| among treatments | 5 |
| oocysts enumerated | 5 |
| calf morbidity | 5 |
| retained fetal | 5 |
| among cows | 5 |
| may reduce | 5 |
| infection pattern | 5 |
| optical density | 5 |
| resting behaviour | 5 |
| jaccard index | 5 |
| interaction terms | 5 |
| diarrhea episodes | 5 |
| allergenic proteins | 5 |
| jejunal mucosa | 5 |
| normal distribution | 5 |
| losses due | 5 |
| veterinary practitioners | 5 |
| hutch space | 5 |
| decreased appetite | 5 |
| rd calves | 5 |
| collected directly | 5 |
| parvum genotype | 5 |
| cattle diarrhea | 5 |
| sporadic human | 5 |
| day interaction | 5 |
| coli isolation | 5 |
| repeated measurements | 5 |
| time period | 5 |
| distal small | 5 |
| six weeks | 5 |
| diarrhea index | 5 |
| health scores | 5 |
| first meal | 5 |
| clayton index | 5 |
| earlier studies | 5 |
| described using | 5 |
| calves based | 5 |
| large animal | 5 |
| water bowls | 5 |
| igy antibodies | 5 |
| showed significantly | 5 |
| consultation group | 5 |
| virus particles | 5 |
| sas version | 5 |
| cebu study | 5 |
| least three | 5 |
| common disease | 5 |
| se dams | 5 |
| poor suckle | 5 |
| cryptosporidiosis among | 5 |
| generally accepted | 5 |
| shed bcv | 5 |
| young dutch | 5 |
| much higher | 5 |
| increased incidence | 5 |
| ill calves | 5 |
| field trials | 5 |
| incidence rates | 5 |
| phase extraction | 5 |
| host specificity | 5 |
| monitoring system | 5 |
| digestive system | 5 |
| wide geographic | 5 |
| safety risk | 5 |
| aerial pollutants | 5 |
| raw milk | 5 |
| needs index | 5 |
| good hygiene | 5 |
| calf weaning | 5 |
| lower saxony | 5 |
| appendix table | 5 |
| altered faecal | 5 |
| supplementary material | 5 |
| related resistance | 5 |
| subunit vaccine | 5 |
| franklin lakes | 5 |
| vet clin | 5 |
| bacterial flora | 5 |
| correlation coefficient | 5 |
| enteric shedding | 5 |
| road transport | 5 |
| test endpoints | 5 |
| severe cases | 5 |
| gnotobiotic calf | 5 |
| fa ratio | 5 |
| also associated | 5 |
| southern california | 5 |
| bacteria counts | 5 |
| calves molecular | 5 |
| quercetin feeding | 5 |
| cow vaccination | 5 |
| every calf | 5 |
| true negative | 5 |
| table iii | 5 |
| preventive measures | 5 |
| lacombe research | 5 |
| herd sizes | 5 |
| low prevalence | 5 |
| frozen colostrum | 5 |
| high enough | 5 |
| rearing conditions | 5 |
| coronavirus strains | 5 |
| may contain | 5 |
| rotavirus excretion | 5 |
| moderate disease | 5 |
| information criterion | 5 |
| intern med | 5 |
| beef farms | 5 |
| cattle populations | 5 |
| chosen based | 5 |
| mesenteric lymph | 5 |
| sequencing kit | 5 |
| label use | 5 |
| older studies | 5 |
| periparturient rise | 5 |
| local antibody | 5 |
| categorical variable | 5 |
| transmission dynamics | 5 |
| serum sodium | 5 |
| cell counts | 5 |
| energy balance | 5 |
| se cows | 5 |
| faecal prevalences | 5 |
| replacement management | 5 |
| colostral antibody | 5 |
| colostrum replacers | 5 |
| binomial distribution | 5 |
| adverse effect | 5 |
| normal calves | 5 |
| system function | 5 |
| body composition | 5 |
| fluid loss | 5 |
| immune protection | 5 |
| group sizes | 5 |
| supranutritional se | 5 |
| single infections | 5 |
| feeding holstein | 5 |
| watery feces | 5 |
| see chapter | 5 |
| extra shade | 5 |
| sulfate turbidity | 5 |
| coli infection | 5 |
| providing passive | 5 |
| per liter | 5 |
| leading cause | 5 |
| shed cryptosporidium | 5 |
| intestinal secretion | 5 |
| feeding program | 5 |
| concrete floor | 5 |
| first time | 5 |
| collective pens | 5 |
| taken directly | 5 |
| animals treated | 5 |
| diarrhea incidence | 5 |
| risk managers | 5 |
| pcr assays | 5 |
| half dose | 5 |
| use practices | 5 |
| weeks later | 5 |
| derived oxylipids | 5 |
| random effects | 5 |
| univariable analyses | 5 |
| oocyst morphology | 5 |
| antimicrobial factors | 5 |
| long term | 5 |
| european commission | 5 |
| intestinal flora | 5 |
| states department | 5 |
| disease caused | 5 |
| increased serum | 5 |
| bulk tank | 5 |
| additional milk | 5 |
| consumed less | 5 |
| fecal scoring | 5 |
| investigation period | 5 |
| chain management | 5 |
| final models | 5 |
| lying bouts | 5 |
| mathematical models | 5 |
| water supply | 5 |
| house air | 5 |
| malabsorptive diarrhea | 5 |
| sufficient volume | 5 |
| routinely collected | 5 |
| cell death | 5 |
| biological hazards | 5 |
| severe depression | 5 |
| infected dairy | 5 |
| social contacts | 5 |
| high salinity | 5 |
| coli biotypes | 5 |
| separate pens | 5 |
| dead calves | 5 |
| specific gravity | 5 |
| colostrum produced | 5 |
| using generalized | 5 |
| coli isolated | 5 |
| achieve adequate | 5 |
| treated colostrum | 5 |
| technical assistance | 5 |
| isolates obtained | 5 |
| weaning period | 5 |
| antibiotic treated | 5 |
| mean values | 5 |
| rehydration solutions | 5 |
| sample collection | 5 |
| bacterial counts | 5 |
| hepatic mrna | 5 |
| clin north | 5 |
| acute gastroenteritis | 5 |
| controlled field | 5 |
| preweaning health | 5 |
| assessment tool | 5 |
| susceptible calves | 5 |
| enteric infection | 5 |
| replacers may | 5 |
| may show | 5 |
| less milk | 5 |
| veterinary surgeon | 5 |
| mrna abundances | 5 |
| collected every | 5 |
| dam within | 5 |
| agarose gel | 5 |
| biotype iii | 5 |
| control programmes | 5 |
| two farms | 5 |
| neutralizing antibody | 5 |
| dual enteric | 5 |
| male calves | 5 |
| also increased | 5 |
| daily dose | 5 |
| climatic conditions | 5 |
| hyperimmune bovine | 5 |
| feeding milk | 5 |
| one third | 5 |
| enzootic bronchopneumonia | 5 |
| northeastern spain | 5 |
| cell membrane | 5 |
| adequate amount | 5 |
| virus isolated | 5 |
| effect size | 5 |
| calves allowed | 5 |
| old chicks | 5 |
| successful colostrum | 5 |
| experimental data | 5 |
| oocyst output | 5 |
| core temperature | 5 |
| larger groups | 5 |
| porcine rotavirus | 5 |
| results obtained | 5 |
| low numbers | 5 |
| first described | 5 |
| clinical samples | 5 |
| calves among | 5 |
| rotavirus shedding | 5 |
| remained constant | 5 |
| trial evaluating | 5 |
| acute bvdv | 5 |
| complete block | 5 |
| health records | 5 |
| brazilian cattle | 5 |
| remaining calves | 5 |
| online version | 5 |
| inactivated oil | 5 |
| study team | 5 |
| study found | 5 |
| vaccination program | 5 |
| health plans | 5 |
| per ml | 5 |
| free radicals | 5 |
| linear fashion | 5 |
| good welfare | 5 |
| microscopic examination | 5 |
| histophilus somni | 5 |
| calf population | 5 |
| diarrhoeic samples | 5 |
| case reports | 5 |
| small intestines | 5 |
| lipid peroxidation | 5 |
| infrared thermal | 5 |
| walled oocysts | 5 |
| cent glucose | 5 |
| giardia sp | 5 |
| calves dying | 5 |
| variables included | 5 |
| relatively small | 5 |
| formic acid | 5 |
| brix refractometer | 5 |
| sick animals | 5 |
| measures analysis | 5 |
| nipple use | 5 |
| diarrhea problem | 5 |
| canadian cow | 5 |
| spss inc | 5 |
| may still | 5 |
| calf behavior | 5 |
| health conditions | 5 |
| disease spread | 5 |
| blood concentrations | 5 |
| biofortified alfalfa | 5 |
| different serotypes | 5 |
| pigs prevalence | 5 |
| toxin production | 5 |
| neonatal period | 5 |
| severe dehydration | 5 |
| sodium sulfite | 5 |
| preliminary results | 5 |
| diagnostic testing | 5 |
| high milk | 5 |
| pathogenic micro | 5 |
| deer calves | 5 |
| assessment enabling | 5 |
| pract doi | 5 |
| first calving | 5 |
| randomized complete | 5 |
| contaminated bedding | 5 |
| fresh colostrum | 5 |
| enabling quantitative | 5 |
| fecal smear | 5 |
| animals within | 5 |
| drug exposure | 5 |
| increased free | 5 |
| hazards associated | 5 |
| collected via | 5 |
| liquid feces | 5 |
| parasitol doi | 5 |
| blood ph | 5 |
| relationships among | 5 |
| human disease | 5 |
| oral antimicrobial | 5 |
| recent findings | 5 |
| may help | 5 |
| beef herd | 5 |
| two months | 5 |
| vet intern | 5 |
| elisa kit | 5 |
| fed low | 5 |
| generic principles | 5 |
| lactic acid | 5 |
| map prevalence | 5 |
| fully functional | 5 |
| bobwhite quail | 5 |
| acquired diarrhea | 5 |
| also significantly | 5 |
| respiratory coronavirus | 5 |
| enzootic pneumonia | 5 |
| blood serum | 5 |
| clinical respiratory | 5 |
| gp subtype | 5 |
| tissue damage | 5 |
| dna analysis | 5 |
| gastrointestinal infections | 5 |
| gnotobiotic piglets | 5 |
| supplement products | 5 |
| undifferentiated diarrhea | 5 |
| sugar fermentation | 5 |
| calves feeding | 5 |
| study dairies | 5 |
| nonpasteurized colostrum | 5 |
| experimental period | 5 |
| mycobacterium paratuberculosis | 5 |
| less painful | 5 |
| ldh activity | 5 |
| scientific panel | 5 |
| fat content | 5 |
| challenge studies | 5 |
| one animal | 5 |
| rna gene | 5 |
| also included | 5 |
| calves inoculated | 5 |
| intramammary infection | 5 |
| calves disbudded | 5 |
| perfringens type | 5 |
| infected herds | 5 |
| older age | 5 |
| oral electrolytes | 5 |
| functional capacity | 5 |
| milk refusal | 5 |
| relatively common | 5 |
| free pufa | 5 |
| breeding females | 5 |
| continuous variables | 5 |
| standard error | 5 |
| studies demonstrated | 5 |
| one day | 5 |
| milking herd | 5 |
| containing specific | 5 |
| subclinical infections | 5 |
| saginata cysticercus | 5 |
| experimental pens | 5 |
| proximal jejunum | 5 |
| continued feeding | 5 |
| volume consumed | 5 |
| alpaca crias | 5 |
| milk feeder | 5 |
| good management | 5 |
| skin tent | 5 |
| general health | 5 |
| meleagridis infection | 5 |
| positive control | 5 |
| venous blood | 5 |
| total body | 5 |
| colostrum supply | 5 |
| month old | 5 |
| avian genotype | 5 |
| ontario holstein | 5 |
| left empty | 5 |
| linearly increased | 5 |
| commercial vaccine | 5 |
| ovis aries | 5 |
| using sas | 5 |
| tag number | 5 |
| british columbia | 5 |
| fibrinogen concentration | 5 |
| cryptosporidiosis amongst | 5 |
| important components | 5 |
| prevalence data | 5 |
| diagnostic tests | 5 |
| bovis vaccines | 5 |
| cryptosporidium suis | 5 |
| gnotobiotic pigs | 5 |
| phosphate buffered | 5 |
| undifferentiated neonatal | 5 |
| rights reserved | 5 |
| sampling days | 5 |
| within herd | 5 |
| higher use | 5 |
| farm staff | 5 |
| intestinal transit | 5 |
| antigenic relationships | 5 |
| probably caused | 5 |
| universal risk | 5 |
| guinea pigs | 5 |
| operating procedures | 5 |
| animal needs | 5 |
| previously published | 5 |
| critical control | 5 |
| low concentrations | 5 |
| pooled colostrum | 5 |
| normal cows | 5 |
| large intestines | 5 |
| link function | 5 |
| young ruminants | 5 |
| nutritional plane | 5 |
| boehringer ingelheim | 5 |
| less severe | 5 |
| fecal sampling | 5 |
| specific immunoglobulins | 5 |
| cryptosporidium ubiquitum | 5 |
| salinity water | 5 |
| depression score | 5 |
| reduced risk | 5 |
| oxylipid profiles | 5 |
| white scours | 5 |
| calf farm | 5 |
| yolk antibodies | 5 |
| environmental samples | 5 |
| per se | 5 |
| meier survival | 5 |
| infection dynamics | 5 |
| important role | 5 |
| starter grain | 5 |
| cattle herd | 5 |
| intestinal damage | 5 |
| future studies | 5 |
| human infections | 5 |
| electrolyte therapy | 5 |
| animals may | 5 |
| analysis identified | 5 |
| outcome variable | 5 |
| gp gene | 5 |
| receive colostrum | 5 |
| disease transmission | 5 |
| paromomycin sulphate | 5 |
| normal calf | 5 |
| clinically affected | 5 |
| increased linearly | 5 |
| highly variable | 5 |
| diarrheagenic escherichia | 5 |
| drink water | 5 |
| decrease mortality | 5 |
| pathogens may | 5 |
| york holstein | 5 |
| rumen capacity | 5 |
| molecular analysis | 5 |
| estimating equations | 5 |
| herd trials | 5 |
| zealand dairy | 5 |
| growth retardation | 5 |
| fresh water | 5 |
| milk flow | 5 |
| three methods | 5 |
| baileyi isolated | 5 |
| calf day | 5 |
| weaning strategies | 5 |
| calf disease | 5 |
| second feeding | 5 |
| reporting calf | 5 |
| oral antibiotics | 5 |
| bloody diarrhea | 5 |
| south bohemia | 5 |
| calves associated | 5 |
| confidence intervals | 5 |
| virus transmission | 5 |
| animals kept | 5 |
| iv treatment | 5 |
| phase bottle | 5 |
| animals infected | 5 |
| oocyst enumeration | 5 |
| floor space | 5 |
| genetic diversity | 5 |
| diarrhoeic calf | 5 |
| generalized linear | 5 |
| colostrum contains | 5 |
| efficacy studies | 4 |
| domestic ruminants | 4 |
| border enzymes | 4 |
| severe disease | 4 |
| calves sampled | 4 |
| overall prevalence | 4 |
| sodium concentration | 4 |
| bactrian camel | 4 |
| events per | 4 |
| science vol | 4 |
| calf age | 4 |
| tank milk | 4 |
| swab specimens | 4 |
| fed varying | 4 |
| mucosal scrapings | 4 |
| injectable antimicrobial | 4 |
| different stages | 4 |
| across time | 4 |
| conventional calves | 4 |
| inappetent calves | 4 |
| cryptosporidiosis cases | 4 |
| whose haemoglobin | 4 |
| one month | 4 |
| new calf | 4 |
| additional articles | 4 |
| manure soiling | 4 |
| coli vaccine | 4 |
| endothelial cells | 4 |
| effective farm | 4 |
| diagnostic methods | 4 |
| recent review | 4 |
| wooden slats | 4 |
| five freedoms | 4 |
| swine farms | 4 |
| calf death | 4 |
| cryptosporidial infections | 4 |
| species cryptosporidium | 4 |
| lactate dehydrogenase | 4 |
| live vaccine | 4 |
| atypical strain | 4 |
| experimental trial | 4 |
| immunoglobulin content | 4 |
| calves intestinal | 4 |
| colostrum products | 4 |
| calves naturally | 4 |
| also thank | 4 |
| cattle bovine | 4 |
| ordered chronologically | 4 |
| detrimental effect | 4 |
| sequences deposited | 4 |
| first detected | 4 |
| beneficial bacteria | 4 |
| also consistent | 4 |
| genus cryptosporidium | 4 |
| adjacent pens | 4 |
| financial support | 4 |
| paulo state | 4 |
| significant associations | 4 |
| calfhood morbidity | 4 |
| electrolyte powder | 4 |
| biocide fusion | 4 |
| diarrhea outbreak | 4 |
| haemoglobin concentrations | 4 |
| chemotherapeutic agents | 4 |
| disease onset | 4 |
| calves originated | 4 |
| produced urease | 4 |
| michigan due | 4 |
| dehydrated calves | 4 |
| beef industry | 4 |
| acute enteritis | 4 |
| intestinal wall | 4 |
| particular reference | 4 |
| dm lipid | 4 |
| agglutination test | 4 |
| inflammatory drugs | 4 |
| reference range | 4 |
| animal treatment | 4 |
| calves three | 4 |